Oil, Gas and Shale
Advertisement




Advertisement




Advertisement




Advertisement




Advertisement




Advertisement




AstraZeneca Partners with Vanguard in Multi-year RNG Deal

Published: June 14, 2023 |

[Click image to enlarge]

[Click image to enlarge]

In a first-of-its-kind collaboration, AstraZeneca (AZN) is partnering with Vanguard Renewables to enable the delivery of renewable natural gas (RNG) to all of its sites in the United States by the end of 2026.

From June 2023, AstraZeneca will begin purchasing RNG produced by Vanguard Renewables for its Newark Campus in Delaware, where the company packages 26 medicines for distribution across the U.S. and makes medicine formulations for global supply. By 2026, this collaboration will enable as much as 650,000 million British thermal units (MMBtu), or 190,500 megawatt hours (MWh) per year, of RNG to be used across AstraZeneca’s U.S. sites, equivalent to the energy required to heat more than 17,800 U.S. homes for a year.

“We recognize the interconnection between the health of people and the planet, and are committed to driving deep decarbonization across our operations and value chain. Our innovative partnership with Vanguard Renewables in the U.S. is an illustration of how we are collaborating at scale to deliver sustainable science and medicines, as part of the transition to net zero health systems and a circular economy,” said Pam Cheng, executive vice president of Global Operations & IT and chief sustainability officer at AstraZeneca.

AstraZeneca is taking a science-led, patient-centric approach to deliver improved health outcomes with a lower environmental footprint. As heat and power are critical to the manufacture of medicines, the decarbonization of healthcare requires access to clean sources of heat, such as RNG. This new partnership with Vanguard Renewables is an important milestone in delivering emissions reductions in line with AstraZeneca’s flagship Ambition Zero Carbon program. The company is on track to reduce greenhouse gas (GHG) emissions from its global operations (scope 1 and 2) by 98 percent by 2026 from a 2015 baseline, and by 2030, AstraZeneca aims to halve its entire value chain footprint on the way to becoming science-based ​net zero by 2045 at the latest. The use of RNG at AstraZeneca sites in the U.S. will further enable the company’s transition to 100 percent renewable energy for heat and power. 

This agreement will utilize Vanguard Renewables Farm Powered® process, allowing Vanguard Renewables to work with dairy farmers and food and beverage manufacturers, retailers, and distributors to produce RNG using farm-based anaerobic digestion (AD) from food and dairy cow manure. Once the RNG is produced and captured through AD, it will be injected into existing natural gas infrastructure for use in AstraZeneca medicines research and manufacturing processes.

Through the partnership with Vanguard Renewables, AstraZeneca will access high quality RNG from three on-farm anaerobic digester facilities across the U.S. for the next 15 years or more.

“Vanguard Renewables is excited to be partnering with AstraZeneca on this transformative business-to-business clean energy solution. AstraZeneca has set a very ambitious and challenging net zero target, which is a benchmark for their sector and other global corporations,” said Neil Smith, chief executive officer at Vanguard Renewables.

“We strongly believe this partnership will provide a path for other like-minded companies to join us on the journey towards global decarbonization,” added Smith.

This collaboration will utilize food and waste from local and family-owned farms, supporting rural communities across the U.S. By capturing methane from dairy operations that would have otherwise ended up in the atmosphere, this partnership also reduces pollution from the farming sector. Vanguard Renewables has been working with multi-generational dairy farms and food and beverage manufacturers since 2014, providing sustainable solutions to greenhouse gas emissions challenges by diverting food waste from landfills and sequestering on-farm emissions. Vanguard’s Farm Powered process provides dairy farmers across the U.S. with an additional revenue stream via land lease, supports regenerative agriculture practices, and helps to ensure that these farms will be operating for years to come.

“We have been working with multi-generational farms and food and beverage manufacturers since 2014 to provide sustainable solutions to greenhouse gas emissions challenges by diverting food waste from landfills and sequestering on-farm emissions,” said John Hanselman, chief strategy officer at Vanguard Renewables.

“Vanguard’s Farm Powered process provides farmers across the U.S. with additional revenue streams, supports regenerative agriculture practices, and helps to ensure that these farms will be operating for years to come — thanks in part to change-making partnerships like this with AstraZeneca,” added Hanselman.


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative medicines are used by millions of patients worldwide.


Vanguard Renewables is a national leader in the development of organics-to-renewable energy projects.


Be in-the-know when you’re on-the-go!

FREE eNews delivery service to your email twice-weekly. With a focus on lead-driven news, our news service will help you develop new business contacts on an on-going basis.

CLICK HERE to register your email address.


Copyright © 2023 Mining Connection LLC. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.

For licensing permission, .(JavaScript must be enabled to view this email address)

Advertisement




Advertisement




Advertisement




Advertisement




Advertisement




Advertisement